Morgan Stanley’s TriSalus Life Sciences TLSI Stock Holding History

Morgan Stanley’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.58M	Buy	393,909 +28,654	+8%	+$140K	﹤0.01%	4904
2025 Q4	$2.55M	Buy	365,255 +347,278	+1,932%	+$1.94M	﹤0.01%	4641
2025 Q3	$83.6K	Sell	17,977 -38,351	-68%	-$180K	﹤0.01%	6232
2025 Q2	$307K	Buy	56,328 +53,967	+2,286%	+$290K	﹤0.01%	5679
2025 Q1	$13K	Buy	+2,361	New	+$12.6K	﹤0.01%	6724
2024 Q4	–	Sell	-1,135	Closed	-$5.23K	–	8087
2024 Q3	$5.23K	Sell	1,135 -837	-42%	-$4.43K	﹤0.01%	6908
2024 Q2	$10.9K	Sell	1,972 -11,337	-85%	-$96.1K	﹤0.01%	6652
2024 Q1	$130K	Sell	13,309 -11,669	-47%	-$108K	﹤0.01%	5889
2023 Q4	$211K	Buy	24,978 +23,841	+2,097%	+$123K	﹤0.01%	5926
2023 Q3	$5.82K	Buy	+1,137	New	+$9.31K	﹤0.01%	6877
2023 Q1	–	Sell	-4,050	Closed	-$40.6K	–	7824
2022 Q4	$40.6K	Hold	4,050	–	–	﹤0.01%	6380
2022 Q3	$40K	Hold	4,050	–	–	﹤0.01%	6504
2022 Q2	$40K	Hold	4,050	–	–	﹤0.01%	6708
2022 Q1	$40K	Hold	4,050	–	–	﹤0.01%	6808
2021 Q4	$40K	Sell	4,050 -154	-4%	-$1.53K	﹤0.01%	6915
2021 Q3	$42K	Buy	4,204 +4,104	+4,104%	+$40.2K	﹤0.01%	6795
2021 Q2	$1K	Sell	100 -125	-56%	-$1.23K	﹤0.01%	7632
2021 Q1	$2K	Buy	+225	New	+$2.28K	﹤0.01%	7284

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Morgan Stanley's TLSI Position: Q1 2026 in Review

Morgan Stanley increased its TriSalus Life Sciences (TLSI) stake by 7.8% in Q1 2026, buying an estimated $140K and bringing the position to 393,909 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #4904.

Morgan Stanley first reported a position in TLSI in Q1 2021 and has held it in 18 quarters since. The position peaked at $2.55M in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

Morgan Stanley held 393,909 shares of TriSalus Life Sciences worth $1.58M as of Q1 2026.
Morgan Stanley bought 28,654 TriSalus Life Sciences shares in Q1 2026, an estimated $140K.
TriSalus Life Sciences made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4904 holding.
Morgan Stanley first reported a position in TriSalus Life Sciences in Q1 2021 and has held it in 18 quarters since.
Morgan Stanley's TriSalus Life Sciences position peaked at $2.55M in Q4 2025.
84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.